(Circulation. 2001;104:3132.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, and Pharmaceutical Research Laboratories, Suntory Biomedical Research Ltd, Osaka (K.M.), Japan.
Correspondence to Tomohiro Osanai, MD, The Second Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562 Japan. E-mail osanait{at}cc.hirosaki-u.ac.jp
Background We showed that mitochondrial coupling factor 6 (CF6), an endogenous inhibitor of prostacyclin synthesis, is present in the systemic circulation as a pressor substance in rats. We investigated the possibility of vascular endothelial cells as a source of circulating CF6.
Methods and Results We used 2 cultured endothelial cell lines, human umbilical vein endothelial cells (HUVECs) and ECV 304 cells (transformed HUVECs), for this study. Immunofluorescence microscopy of both ECV 304 and HUVECs confirmed the surface-associated immunoreactivity of anti-CF6 antibody on the plasma membrane. The concentration of CF6 in the medium increased gradually with time in both ECV 304 and HUVECs in static conditions. Exposure of ECV 304 and HUVECs to a fluid shear stress enhanced the release of CF6: In ECV 304, the concentration of CF6 in the medium (ng · well-1 · 6 hours-1) was 2.1±0.8 at baseline, 4.3±0.8 after shear at 15 dynes/cm2, and 57.7±8.4 after shear at 25 dynes/cm2. CF6 contents in the cell homogenate and mitochondria were both significantly increased after exposure of ECV 304 to 6-hour shear at 15 dynes/cm2, whereas they were unchanged after shear stress at 25 dynes/cm2. The ratio of CF6 to GAPDH mRNA was enhanced significantly, by 1.8±0.2-fold, after 6-hour shear stress at 25 dynes/cm2. Flow cytometry analysis revealed that the surface-associated CF6 was significantly increased in a 3-hour static condition after the previous exposure of the cells to shear stress for 3 hours.
Conclusions Vascular endothelial cells are a source of CF6, and shear stress regulates the release of the surface-associated CF6.
Key Words: endothelium blood flow hormones prostaglandins vasoconstriction
This article has been cited by other articles:
![]() |
T. Osanai, K. Magota, M. Tanaka, M. Shimada, R. Murakami, S. Sasaki, H. Tomita, N. Maeda, and K. Okumura Intracellular Signaling for Vasoconstrictor Coupling Factor 6: Novel Function of {beta}-Subunit of ATP Synthase as Receptor Hypertension, November 1, 2005; 46(5): 1140 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Watts Vasoconstriction Caused by the ATP Synthase Subunit-Coupling Factor 6: A New Function for a Historical Enzyme Hypertension, November 1, 2005; 46(5): 1100 - 1102. [Full Text] [PDF] |
||||
![]() |
H. Tomita, T. Osanai, T. Toki, S. Sasaki, N. Maeda, R. Murakami, K. Magota, M. Yasujima, and K. Okumura Troglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells Cardiovasc Res, July 1, 2005; 67(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sasaki, T. Osanai, H. Tomita, T. Matsunaga, K. Magota, and K. Okumura Tumor necrosis factor {alpha} as an endogenous stimulator for circulating coupling factor 6 Cardiovasc Res, June 1, 2004; 62(3): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ameshima, H. Golpon, C. D. Cool, D. Chan, R. W. Vandivier, S. J. Gardai, M. Wick, R. A. Nemenoff, M. W. Geraci, and N. F. Voelkel Peroxisome Proliferator-Activated Receptor Gamma (PPAR{gamma}) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth Circ. Res., May 30, 2003; 92(10): 1162 - 1169. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |